Researchers value AICAR for its ability to model bioenergetic stress and adaptive metabolic responses. It supports experiments investigating glucose uptake, fatty-acid oxidation, and intracellular ATP homeostasis under variable conditions. Additionally, the AICAR peptide allows direct comparison with other AMPK agonists to understand pathway selectivity and signaling depth.
Laboratories often use the AICAR peptide for:
-
Mapping AMPK activation and downstream metabolic signaling
-
Analysing cellular responses to energy availability shifts
-
Studying glucose-metabolism pathways and mitochondrial function
-
Comparing AMP-analogue activity in controlled environments
Because AICAR produces clear and measurable changes in intracellular signaling, it supports data reproducibility and precise mechanistic analysis. Its stability and well-characterized mode of action make it suitable for structured metabolic modeling, in-vitro assays, and ex-vivo pathway investigations.
Our AICAR peptide is supplied as a high-purity laboratory reagent intended strictly for qualified scientific research. It is not approved for clinical, therapeutic, diagnostic, or veterinary use. All handling requires adherence to institutional and regulatory safety protocols for experimental metabolic compounds.
For research use only. Not for human consumption.